| Nutritional therapy in cirrhosis or alcoholic hepatitis: a systematic review and meta‐analysis AD Fialla, M Israelsen, O Hamberg, A Krag, LL Gluud Liver International 35 (9), 2072-2078, 2015 | 153 | 2015 |
| Prognostic performance of 7 biomarkers compared to liver biopsy in early alcohol-related liver disease DN Rasmussen, M Thiele, S Johansen, M Kjærgaard, KP Lindvig, ... Journal of hepatology 75 (5), 1017-1025, 2021 | 101 | 2021 |
| Terlipressin versus other vasoactive drugs for hepatorenal syndrome M Israelsen, A Krag, AS Allegretti, M Jovani, AH Goldin, RW Winter, ... Cochrane Database of Systematic Reviews, 2017 | 93 | 2017 |
| Acute kidney injury and hepatorenal syndrome in cirrhosis M Egerod Israelsen, LL Gluud, A Krag Journal of gastroenterology and hepatology 30 (2), 236-243, 2015 | 80 | 2015 |
| Terlipressin versus placebo or no intervention for people with cirrhosis and hepatorenal syndrome AS Allegretti, M Israelsen, A Krag, M Jovani, AH Goldin, AR Schulman, ... Cochrane Database of Systematic Reviews, 2017 | 76 | 2017 |
| Metabolic and genetic risk factors are the strongest predictors of severity of alcohol-related liver fibrosis M Israelsen, HB Juel, S Detlefsen, BS Madsen, DN Rasmussen, ... Clinical Gastroenterology and Hepatology 20 (8), 1784-1794. e9, 2022 | 65 | 2022 |
| Using the ELF test, FIB-4 and NAFLD fibrosis score to screen the population for liver disease M Kjaergaard, KP Lindvig, KH Thorhauge, P Andersen, JK Hansen, ... Journal of hepatology 79 (2), 277-286, 2023 | 57 | 2023 |
| Effect of calorie-unrestricted low-carbohydrate, high-fat diet versus high-carbohydrate, low-fat diet on type 2 diabetes and nonalcoholic fatty liver disease: a randomized … CD Hansen, EM Gram-Kampmann, JK Hansen, MB Hugger, BS Madsen, ... Annals of Internal Medicine 176 (1), 10-21, 2023 | 48 | 2023 |
| 2D shear wave liver elastography by Aixplorer to detect portal hypertension in cirrhosis: an individual patient data meta‐analysis M Thiele, MB Hugger, Y Kim, PE Rautou, L Elkrief, C Jansen, W Verlinden, ... Liver international 40 (6), 1435-1446, 2020 | 47 | 2020 |
| Development, validation, and prognostic evaluation of a risk score for long-term liver-related outcomes in the general population: a multicohort study M Serra-Burriel, A Juanola, F Serra-Burriel, M Thiele, I Graupera, E Pose, ... The Lancet 402 (10406), 988-996, 2023 | 41 | 2023 |
| Rifaximin-α for liver fibrosis in patients with alcohol-related liver disease (GALA-RIF): a randomised, double-blind, placebo-controlled, phase 2 trial M Israelsen, BS Madsen, N Torp, S Johansen, CD Hansen, S Detlefsen, ... The Lancet Gastroenterology & Hepatology 8 (6), 523-532, 2023 | 34 | 2023 |
| Collagen proportionate area predicts clinical outcomes in patients with alcohol‐related liver disease M Israelsen, M Guerrero Misas, A Koutsoumourakis, Y Huang, M Thiele, ... Alimentary pharmacology & therapeutics 52 (11-12), 1728-1739, 2020 | 31 | 2020 |
| Comprehensive lipidomics reveals phenotypic differences in hepatic lipid turnover in ALD and NAFLD during alcohol intoxication M Israelsen, M Kim, T Suvitaival, BS Madsen, CD Hansen, N Torp, K Trost, ... JHEP Reports 3 (5), 100325, 2021 | 30 | 2021 |
| MetALD: new opportunities to understand the role of alcohol in steatotic liver disease M Israelsen, N Torp, S Johansen, M Thiele, A Krag The Lancet Gastroenterology & Hepatology 8 (10), 866-868, 2023 | 22 | 2023 |
| Validation of the new nomenclature of steatotic liver disease in patients with a history of excessive alcohol intake: an analysis of data from a prospective cohort study M Israelsen, N Torp, S Johansen, CD Hansen, ED Hansen, K Thorhauge, ... The Lancet Gastroenterology & Hepatology 9 (3), 218-228, 2024 | 19 | 2024 |
| Antifibrotic and molecular aspects of rifaximin in alcoholic liver disease: study protocol for a randomized controlled trial BS Madsen, J Trebicka, M Thiele, M Israelsen, M Arumugan, T Havelund, ... Trials 19, 1-5, 2018 | 18 | 2018 |
| Binge drinking induces an acute burst of markers of hepatic fibrogenesis (PRO‐C3) N Torp, M Israelsen, MJ Nielsen, CP Åstrand, P Juhl, S Johansen, ... Liver International 42 (1), 92-101, 2022 | 16 | 2022 |
| Dobutamine reverses the cardio-suppressive effects of terlipressin without improving renal function in cirrhosis and ascites: a randomized controlled trial M Israelsen, EK Dahl, BS Madsen, S Wiese, F Bendtsen, S Møller, ... American Journal of Physiology-Gastrointestinal and Liver Physiology 318 (2 …, 2020 | 14 | 2020 |
| Sphingolipids are depleted in alcohol-related liver fibrosis M Thiele, T Suvitaival, K Trošt, M Kim, A de Zawadzki, M Kjaergaard, ... Gastroenterology 164 (7), 1248-1260, 2023 | 11 | 2023 |
| Noninvasive assessment of hepatic decompensation M Thiele, S Johansen, M Israelsen, J Trebicka, JG Abraldes, P Gines, ... Hepatology, 10.1097, 2023 | 10 | 2023 |
